Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
about
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathyPrevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complexTransient apical ballooning in hypertrophic obstructive cardiomyopathy.Calcified aneurysm of left ventricular apex in apical cardiomyopathy.Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy.Angina-like chest pain and syncope as the clinical presentation of left ventricular endomyocardial fibrosis: a case report.Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathySudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers.Acute hemodynamic deterioration during rapid atrial pacing in patients with hypertrophic cardiomyopathy.PET measurement of the coronary flow reserve and microcirculatory function.Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.Peripheral vascular endothelial function in patients with hypertrophic cardiomyopathy.Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy.Blood vessel repair and regeneration in the ischaemic heartSystolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy.Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosisEffect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy.A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole.Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography.Recent advances in diagnosis and management of hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy: prognosis with medical or surgical therapy.Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study.Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathyEffects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy.The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.Nuclear cardiac imaging in hypertrophic cardiomyopathy.Current perspectives in hypertrophic cardiomyopathy: diagnosis, clinical management, and prevention of disability and sudden cardiac death.Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography.Multimodality imaging in apical hypertrophic cardiomyopathy.Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review.Myocardial ischemia without atherosclerosis.Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.Systolic compression of intramural coronary arteries in hypertrophic cardiomyopathy.Impaired myocardial perfusion in patients with hypertrophic cardiomyopathy: assessment with digital subtraction coronary arteriography.The clinical significance of nonsustained ventricular tachycardia: current perspectives.Reversible ischaemia in hypertrophic cardiomyopathy.Short term reduction of left ventricular mass in primary hypertrophic cardiomyopathy by octreotide injections.
P2860
Q24197872-1242AF5C-4E06-4066-A738-2F2F3DB9A73DQ28346540-EA773B6F-0770-470F-9057-CC0B0858C8ACQ30485155-284587A8-9AA1-4940-B0A1-2D3AF413AB86Q30525386-103900ED-CADF-43A8-BE1D-6A3F70872E70Q30535399-B6C646B7-3209-47B0-9AEC-7FC5C601F647Q33152679-63101B55-2C3F-4510-A6F6-EBB469CE54B7Q33152812-D3693615-6F73-44D4-8940-503F6C9D2A74Q33173818-C747BFFB-EDA6-47A4-A390-2B60C087A046Q33174748-EF4BBD08-E412-4BE5-87E1-B7AB45EDF690Q33802855-965FF763-D92D-4B45-A12C-C89A2A0CCFA3Q33872015-06BC7CDF-9670-4462-8ECF-067132C8A10BQ34056127-EC953A6E-B25F-4868-86F4-8EE933D9BD1AQ34071911-D43FC18E-467B-455C-AF8D-2D65D7F25F81Q34140784-8A4787AF-0999-4775-AA1E-DB6A57E271DBQ34304413-B64B4730-4F47-455C-A734-9D57C75EF0E9Q34452081-2807B549-EDE6-4358-8908-F49DBE178BD1Q34561038-521EDE29-0FDE-4964-BB4B-24EBC34E4804Q35375143-6464D5D7-D051-4AFB-A019-1EF887501159Q35567345-5330A952-09EF-447B-B06A-72158653CB0CQ35820263-E7A79631-E614-4C9F-B220-850D0BB2955CQ36025727-667E24C8-8061-48A8-B009-2C19624EA7B1Q36057471-6A21E8C7-0813-4DF1-B3EC-2B70B0D9D01BQ36492134-1198657B-88F4-43C6-9A6D-7CBC0FDB09C4Q36676229-67C33945-E339-4E2C-8791-E515DA554DB0Q36829563-57DD160F-1216-4679-A9DA-0AE61FFBA330Q36837022-043DDE9A-D6BC-4A7B-91A2-BAE542F1E86AQ37766174-D527A2FA-E3E7-4D1B-A3BA-DC82E0A2376DQ37782285-848DDC85-EE59-4902-9F62-C7E465FBA273Q37930066-159CD347-1E27-462A-B50D-56BA3667D790Q38059853-67CBFDE0-E133-494D-A0B5-D661DCF93C8EQ38256156-116ECCD4-D194-49C1-BA81-73A346B80836Q38343713-B4979F55-4255-4198-BC5C-B2306343860CQ38572711-658326D4-4115-460A-9F00-6F468990FA37Q38701235-B36274D4-6AA0-4089-ACEA-D663B7E3F0CBQ38816364-DFA34FE5-F48D-49A4-BFDE-DB4F5D5B740BQ39174285-30C58331-2BED-48B1-8A49-CE1D590F80E2Q39287517-2D1E9495-91EA-41AE-BC91-EA54F80341EAQ40390031-67E0FAEC-2788-4AA9-A20F-CB2612793270Q41336225-226731FE-E911-40D2-8272-7CB500F9AD9FQ41341335-16884146-EC26-4508-A45D-9B1E6933F383
P2860
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Myocardial ischemia in patient ...... ventricular filling pressures.
@en
Myocardial ischemia in patient ...... ventricular filling pressures.
@nl
type
label
Myocardial ischemia in patient ...... ventricular filling pressures.
@en
Myocardial ischemia in patient ...... ventricular filling pressures.
@nl
prefLabel
Myocardial ischemia in patient ...... ventricular filling pressures.
@en
Myocardial ischemia in patient ...... ventricular filling pressures.
@nl
P2093
P356
P1433
P1476
Myocardial ischemia in patient ...... ventricular filling pressures.
@en
P2093
Cannon RO 3rd
Epstein SE
P304
P356
10.1161/01.CIR.71.2.234
P407
P577
1985-02-01T00:00:00Z